Summary Notification Information Format (SNIF) for MVA-NSmut

Year: 2014

Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine MVA-NSmut

Newspaper Notice, Southside People, 16 April 2014

Year: 2014

Newspaper Notice, Southside People, 16 April 2014

G0536-01 Consent Conditions

Year: 2014

G0536-01 Consent Conditions issued to The GUIDE Department, St. James's Hospital, Dublin on 22 July 2014 for a clinical trial using a Genetically Modified Organism (GMO)

Environmental Risk Assessment for MVA-NSmut

Year: 2014

Environmental Risk Assessment for Modified recombinant virus vaccine MVA-NSmut

Environmental Risk Assessment for AdCh3NSmut1

Year: 2014

Environmental Risk Assessment for Modified recombinant virus vaccine AdCh3NSmut1

How to make a Representation

Year: 2014

How to make a Representation to the EPA regarding Deliberate Release G0536-01

Summary Notification Information Format (SNIF) for MVA-NSmut

Year: 2014

Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine MVA-NSmut

Summary Notification Information Format (SNIF) AdCh3NSmut1

Year: 2014

Summary Notification Information Format (SNIF) for Modified recombinant virus vaccine AdCh3NSmut1

Notice to Local Authorities

Year: 2014

Notice circulated to Local Authorities regarding requirements of Industrial Emissions Directive and Regulations

Equilis RhodE Trial - Final Report

Year: 2014

Final report on the Equilis RhodE veterinary trial

Intervet Letter of 10 March 2014 re cessation of trial

Year: 2014

Correspondence received from Intervet International B.V. on 10 March 2014 to advise the Agency of their decision to stop the veterinary trial

International Credit Entitlement for Operators

Year: 2013

In accordance with Article 2.1 of Commission Regulation (EU) No. 1123/2013. International Credit Entitlement for Operators. Please be advised that this ICE Table is subject to approval by the European Commission and thus is subject to change.

G0493-01 Inspector's Report to the Board of the Agency

Year: 2013

All documentation submitted in respect of this notification, including valid representations made by members of the public, was taken into consideration by the EPA Inspector in her report to the Board of the Agency.

Inspector's Memo to Board for approval to modify condition

Year: 2013

Inspector's Memo to Board for approval to modify condition

Letter from EPA to Intervet International BV with modified condition

Year: 2013

Letter from EPA to Intervet International BV, dated 11 June 2013, with modified condition

Board Minute Extract re decision on modified condition

Year: 2013

An extract from the Board Minute of the meeting of 10 June 2013,approving the modification of Condition 6.8

G0493-01 Valid representations received from members of the public

Representations received from members of the public in response to Intervet International BV's notification, June 2013

Year: 2013

The following valid representations were submitted in response to the notification by Intervet International BV, seeking consent to carry out a veterinary trial using a genetically modified vaccine

Non-confidential Annex List G0493

Year: 2013

List of non-confidential annexes received as part of Merck Sharp and Dohme/Intervet International BV's application G0493

Board minute extract for Agency Board Meeting of 9 April 2013

Year: 2013

An extract from the minutes of the EPA Board Meeting of 9 April 2013, at which Intervet International BV's notification seeking consent to carry out a veterinary trial at Belmont Stud, Co Offaly, was discussed.

Pagination